Epilepsies, Partial

A Phase III Open-Label Extension Study Of Gabapentin As Adjunctive Therapy In Japanese Pediatric Patients With Partial Seizures

A Phase III Open-Label Study Of Gabapentin As Adjunctive Therapy In Japanese Pediatric Patients With Partial Seizures

Efficacy And Safety Study Of Pregabalin (Lyrica) As Monotherapy In Patients With Partial Seizures

Open-Label Extension Study Of Safety And Tolerability Of Pregabalin In Pediatric Patients With Partial-Onset Seizures

A Double-blind Confirmatory Trial of Levetiracetam in Epilepsy Patients With Partial Onset Seizures

Pregabalin Open-Label Extension Trial in Patients With Partial Seizures

A Study to Evaluate the Efficacy and Safety of Seletracetam in Adult Patients With Refractory Partial Onset Seizures

Safety and Tolerability of Intravenous SPM 927 as Replacement for Oral SPM 927 in Subjects With Partial Seizures

Safety of Cenobamate in Japanese Subjects With Partial Onset Seizures

Open-label Extension to Protocol 1042-0600

Pilot Trial of a Behavioral Treatment for Epilepsy

Study of PK and Safety of OXC (Oxcarbazepine) XR (Extended Release) as Adjunctive Therapy in Pediatric Epilepsy Patients

Compassionate Use Program With Lacosamide in Patients With Partial-onset or Generalized Tonic-clonic Seizures

Microburst Vagus Nerve Stimulator (VNS) Therapy Feasibility Study

Safety and Efficacy of Gabapen for Pediatric (Regulatory Post Marketing Commitment Plan)

Vimpat® Added as Adjunctive Therapy to One Baseline Antiepileptic Drug

Post-Authorization Safety Study to Assess the Safety of Vimpat as add-on Therapy in Patients With Partial-onset Seizures

Drug Use Investigation Of Gabapentin